Lymphoid Neoplasms
📧 Sign up to get email alerts when something new happens for Lymphoid Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Futibatinib in Patients With Specific FGFR Aberrations [Phase 2]
Taiho Oncology reports a Phase 2 trial of futibatinib in patients with FGFR aberrations across advanced cancers. The study (NCT04189445) was…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: ACY-1215 for Relapsed/Refractory Lymphoid Malignancies [Phase 1, Phase 2]
Clinical trial update for ACY-1215 (ricolinostat) in relapsed/refractory lymphoid malignancies reports Phase 1/2 results; the study has been…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 trial evaluating CMC-544 with allogeneic transplantation for CD22-positive lymphoid malignancies has completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating bortezomib with chemotherapy in lymphoid malignancies undergoing stem cell transplantation; results posted…
-
CLINICAL_TRIALS trial_result · 2018-03-02Clinical Trial Update: Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT [NA]
A completed clinical trial evaluated cyclophosphamide and busulfan as conditioning before allogeneic hematopoietic stem cell transplantation…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.